뉴스

WIRobotics Selects Ottobock for WIM S Distribution in North America

2026.11.17조회수 39


WIRobotics announced a North American distribution agreement on November 16, 2026, under which its U.S. subsidiary will supply WIM S and Ottobock will serve as distribution partner for the wearable mobility robot in the United States and Canada. WIRobotics USA Inc. signed the distribution and sales agreement with Otto Bock HealthCare LP on October 15, 2026.

The partnership begins in the United States, where consumers can buy WIM S online through Ottobock’s dedicated direct-to-consumer platform and WIRobotics USA’s online store. They can also initially try the robot at select orthotic and prosthetic clinics. Based on customer feedback, the companies will consider hands-on experiences at more U.S. locations and extending partnership sales to Canada. The initial launch is therefore focused on the U.S. rather than a simultaneous sales start in both countries.


Local Operations Support the Rollout

Ottobock contributes distribution, clinical-care and service networks in the United States and Canada, along with a human-mobility business founded in Germany in 1919. The companies plan to collaborate on market development, brand building, product training and after-sales service. WIRobotics USA will support training and service operations locally, giving the rollout a support structure alongside its online sales channels and clinic demonstrations.

WIRobotics said the broader WIM line is in its third year of commercialization and has surpassed 4,000 units in cumulative sales. The company has expanded beyond South Korea into markets including Europe, China and Japan, and identifies the United States and Canada as key strategic markets. It established WIRobotics USA under General Manager Jacob Kim to build local North American operations.

“Our goal is to make wearable mobility technology easier for people to experience and integrate into everyday life,” said Younbaek Lee, co-CEO of WIRobotics.


Wellness Product, Separate Medical Ambitions

WIRobotics USA’s official product page describes WIM S as a robot worn around the hips with a waist strap and thigh straps. It weighs 3.5 pounds including the battery and all worn parts and has maximum assist torque of 6 newton-metres. Its built-in rechargeable battery is billed as all-day, and Bluetooth pairing lets users select modes and assistance strength and view gait scores and progress.

Air mode assists ordinary walking, Aqua adds resistance, Care supports shorter and slower strides, and Hiking assists on slopes and stairs; Rest switches assistance off. WIRobotics USA expressly classifies WIM S as a wellness activity device, not a medical device, with no FDA clearance and no medical claims.

That classification separates the current consumer rollout from the companies’ potential collaboration on WIM Medi, which WIRobotics is developing for medical use. The companies view WIM Medi as a next step for the partnership, but entry into U.S. and Canadian medical and rehabilitation channels would require applicable regulatory authorization and a separate agreement.

The agreement’s immediate commercial significance is the combination of online sales, clinic trials and local support for the U.S. launch. Canadian partnership sales and WIM Medi offer possible extensions, but the initial deal centers on building distribution and service for WIM S as a wellness product.


출처: Securities.io

https://www.securities.io/wirobotics-selects-ottobock-for-wim-s-distribution-in-north-america/

목록으로